Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Prepaid Assets (2016 - 2026)

Sol-Gel Technologies (SLGL) posted quarterly Prepaid Assets of $1.9 million for Q1 2026, down 28.45% year-over-year from $2.6 million in Q1 2025, and up 88.65% quarter-over-quarter from $1.0 million in Q4 2025.

Analysis

Sol-Gel Technologies (SLGL) Prepaid Assets (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has reported Prepaid Assets for 11 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Prepaid Assets fell 28.45% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (down 28.45% YoY), while the FY2025 annual figure was $1.0 million, down 73.4% from the prior year.
  • Prepaid Assets rose to $1.9 million in Q1 2026 per SLGL's latest filing, from $1.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $3.8 million in Q4 2024 and bottomed at $747000.0 in Q1 2022.
  • Historically, Prepaid Assets has averaged $1.9 million across 5 years, with a median of $1.9 million in 2026.
  • Annual changes were most pronounced in 2022 — Prepaid Assets surged 88.62% — and 2025, when it tumbled 73.4%.
  • Sol-Gel Technologies' Prepaid Assets stood at $1.5 million in 2022, then jumped by 85.16% to $2.8 million in 2023, then jumped by 35.08% to $3.8 million in 2024, then sank by 73.4% to $1.0 million in 2025, then soared by 88.65% to $1.9 million in 2026.
  • Business Quant data shows SLGL's Prepaid Assets at $1.9 million in Q1 2026, $1.0 million in Q4 2025, and $962000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.44 Mn
Mar 31, 2026 1.89 Mn
Dec 31, 2025 1.00 Mn
Sep 30, 2025 962,000.00
Jun 30, 2025 1.94 Mn
Mar 31, 2025 2.65 Mn
Dec 31, 2024 3.77 Mn
Sep 30, 2024 2.88 Mn
Jun 30, 2024 1.75 Mn
Mar 31, 2024 2.12 Mn
Dec 31, 2023 2.79 Mn
Sep 30, 2023 2.15 Mn
Jun 30, 2023 2.41 Mn
Mar 31, 2023 1.13 Mn
Dec 31, 2022 1.51 Mn
Sep 30, 2022 1.47 Mn
Jun 30, 2022 1.69 Mn
Mar 31, 2022 747,000.00
Dec 31, 2021 800,000.00
Sep 30, 2021 1.17 Mn